BBC News
US health secretary RFK Jr plans broader access to unapproved peptides
US Health Secretary RFK Jr intends to make unapproved peptides more accessible. Health experts, however, have advised people not to use these drugs, warning that clinical trials in humans are lacking and the drugs’ effects over the long term are unknown.

What to know
- 01
RFK Jr plans to broaden access to peptides that have not been approved.
- 02
Health experts advise against using the drugs, citing missing human clinical trials and unknown long-term effects.
Why it matters
Because the plan concerns unapproved drugs, the experts’ concerns about missing human trials and unknown long-term effects provide important context for the proposed expansion of access.
AI-assisted brief. Read the source for full details. Editorial & sourcing policy


